9 citations
,
March 2018 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology” Recognizing Jacquet's sign helps diagnose and treat traction alopecia accurately.
June 2025 in “BMJ Case Reports” Axitinib treatment turned a man's grey hair back to black.
Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.
July 2022 in “Zenodo (CERN European Organization for Nuclear Research)” 266 citations
,
January 2016 in “Development” YAP and TAZ are crucial for skin cell growth and repair.
October 2023 in “Open Repository of the University of Porto (University of Porto)” Pharmacists play a crucial role in patient care and optimizing treatment outcomes.
11 citations
,
January 2018 in “Acta dermato-venereologica” Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.
October 2022 in “Amplla Editora eBooks” September 2020 in “Zenodo (CERN European Organization for Nuclear Research)” Reducing Zyxin may help treat hair loss.
25 citations
,
November 2022 in “British journal of dermatology/British journal of dermatology, Supplement” Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.
December 2025 in “Cureus” Zinc supplements effectively treat inherited zinc deficiency in infants.
August 2024 in “OSMANGAZİ JOURNAL OF MEDICINE” The visfatin GT genotype may increase the risk of Alopecia Areata.
December 2023 in “Journal of Medicinal Chemistry” A new topical treatment for hair loss shows strong hair growth effects with low toxicity.
March 2024 in “Nevşehir Hacı Bektaş Veli Üniversitesi SBE Dergisi” Art therapy may help reduce anxiety and depression in people with Alopecia Areata.
13 citations
,
September 1976 in “Archives of Environmental Health An International Journal” Bushman women have higher iron and zinc levels, while American mothers have more copper.
October 2024 in “International Journal of Research in Dermatology” Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.
6 citations
,
January 2008 in “PubMed”
June 2026 in “Frontiers in Immunology” Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.
The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.
October 2025 in “Dermatology and Therapy” Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.
11 citations
,
November 2020 in “bioRxiv (Cold Spring Harbor Laboratory)” Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.
October 2015 in “Reactions Weekly” A woman got a scalp condition from using latanoprost, but it improved after stopping the drug and starting other treatments.
5 citations
,
October 2021 in “Clinical, cosmetic and investigational dermatology” Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.
45 citations
,
June 1984 in “Journal of the American Veterinary Medical Association” Zinc supplements quickly improved health issues in sheep and goats.
February 2023 in “Zenodo (CERN European Organization for Nuclear Research)” June 2026 in “JAAD reviews.”
1 citations
,
March 2004 in “Clinical Medicine” Learn how to avoid mistakes in consultant evaluations.